22nd Century Group Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
56
- Stock Symbol
-
XXII
- Investments
-
8
- Share Price
-
$1.15
- (As of Wednesday Closing)
22nd Century Group General Information
Description
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Contact Information
Website
www.xxiicentury.comCorporate Office
- 321 Farmington Road
- Mocksville, NC
- United States
Corporate Office
- 321 Farmington Road
- Mocksville, NC
- United States
22nd Century Group Timeline
22nd Century Group Stock Performance
As of 14-May-2025, 22nd Century Group’s stock price is $1.15. Its current market cap is $4.71M with 4.1M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.15 | $1.15 | $0.70 - $221.40 | $4.71M | 4.1M | 729K | -$173.97 |
22nd Century Group Financials Summary
As of 31-Dec-2024, 22nd Century Group has a trailing 12-month revenue of $11.9M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 6,954 | 6,954 | 32,380 | 163,025 |
| Revenue | 11,878 | 11,878 | 16,195 | 40,501 |
| EBITDA | (12,185) | (12,185) | (40,633) | (33,199) |
| Net Income | (15,164) | (15,164) | (140,775) | (59,801) |
| Total Assets | 21,673 | 21,673 | 27,503 | 114,651 |
| Total Debt | 8,617 | 8,617 | 16,378 | 1,652 |
22nd Century Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
22nd Century Group Comparisons
Industry
Financing
Details
22nd Century Group Competitors (7)
One of 22nd Century Group’s 7 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel | ||||
| CSL | Corporation | Melbourne, Australia | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| ToolGen | Corporation | Seoul, South Korea |
22nd Century Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
22nd Century Group Patents
22nd Century Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3165518-A1 | A genetic approach for achieving ultra low nicotine content in tobacco | Pending | 08-Jan-2020 | ||
| JP-2023509967-A | A genetic approach to achieve ultra-low nicotine content in tobacco | Pending | 08-Jan-2020 | ||
| US-20230029171-A1 | Genetic approach for achieving ultra low nicotine content in tobacco | Active | 08-Jan-2020 | ||
| EP-4087387-A1 | A genetic approach for achieving ultra low nicotine content in tobacco | Pending | 08-Jan-2020 | ||
| AU-2021205499-A1 | A genetic approach for achieving ultra low nicotine content in tobacco | Inactive | 08-Jan-2020 | A01H1/101 |
22nd Century Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
22nd Century Group Investments & Acquisitions (8)
22nd Century Group’s most recent deal was a Merger/Acquisition with RX Pharmatech for . The deal was made on 19-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RX Pharmatech | 19-Jan-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| GVB Biopharma | 13-May-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Change Agronomy | 26-Jan-2022 | Corporate | Cultivation | ||
| Needle Rock Farms | 01-Jan-2021 | Merger/Acquisition | Other Consumer Non-Durables | ||
| Panacea Life Sciences | 03-Dec-2019 | Corporate | Other Pharmaceuticals and Biotechnology |
22nd Century Group ESG
Risk Overview
Risk Rating
Updated April, 25, 2023
35.44 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,842
Rank
Percentile
Food Products
Industry
of 629
Rank
Percentile
Tobacco
Subindustry
of 24
Rank
Percentile
22nd Century Group Exits (4)
22nd Century Group’s most recent exit was on 13-May-2022 from GVB Biopharma. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| GVB Biopharma | 13-May-2022 | Completed |
|
||
| Needle Rock Farms | 01-Jan-2021 | Completed |
|
||
| Panacea Life Sciences | 03-Dec-2019 | Completed |
|
||
| Anandia | 18-Sep-2014 | Corporate | Completed |
22nd Century Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RX Pharmatech | Bradford, United Kingdom | 2016 |
22nd Century Group FAQs
-
When was 22nd Century Group founded?
22nd Century Group was founded in 1998.
-
Where is 22nd Century Group headquartered?
22nd Century Group is headquartered in Mocksville, NC.
-
What is the size of 22nd Century Group?
22nd Century Group has 56 total employees.
-
What industry is 22nd Century Group in?
22nd Century Group’s primary industry is Biotechnology.
-
Is 22nd Century Group a private or public company?
22nd Century Group is a Public company.
-
What is 22nd Century Group’s stock symbol?
The ticker symbol for 22nd Century Group is XXII.
-
What is the current stock price of 22nd Century Group?
As of 14-May-2025 the stock price of 22nd Century Group is $1.15.
-
What is the current market cap of 22nd Century Group?
The current market capitalization of 22nd Century Group is $4.71M.
-
What is 22nd Century Group’s current revenue?
The trailing twelve month revenue for 22nd Century Group is $11.9M.
-
Who are 22nd Century Group’s competitors?
Zydus Lifesciences, Teva Pharmaceutical Industries, CSL, AbbVie, and ToolGen are some of the 7 competitors of 22nd Century Group.
-
What is 22nd Century Group’s annual earnings per share (EPS)?
22nd Century Group’s EPS for 12 months was -$173.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
